To further investigate whether reduced levels of Itgal modulate ischemic brain injury, and particularly whether these effects were collateral vessel-independent, we employed an ex vivo model of cerebral ischemia, using siRNA to knockdown Itgal expression in cortical brain slices (where collateral circulation is no longer relevant). The gene discussed is ITGAL; the disease is brain ischemia.